Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 14, 2018; 24(2): 257-265
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.257
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.257
Figure 1 Flow diagram of patient inclusion.
Figure 2 Overall survival and disease-free survival curves of the three groups.
OS: Overall survival; DFS: Disease-free survival.
Figure 3 Cumulative frequency of pathological complete remission by neoadjuvant chemotherapy to surgery interval time.
NACT: Neoadjuvant chemotherapy.
- Citation: Liu Y, Zhang KC, Huang XH, Xi HQ, Gao YH, Liang WQ, Wang XX, Chen L. Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes. World J Gastroenterol 2018; 24(2): 257-265
- URL: https://www.wjgnet.com/1007-9327/full/v24/i2/257.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i2.257